Evidence 1
Activity
Activity
IC50
IC50 = 18.3 ± 0.4 µM
Anticancer
18.3
Target
Breast Cancer
MDA-MB-231
Breast
Assay & Model
Not Available
Source & Reference
CancerPPD 2.0
CancerPPD2
2022
Other
| Source Activity Label | Source Definition |
|---|---|
| Anticancer |
CancerPPD 2.0
manually curated experimentally verified anticancer peptide/protein annotation.
|